149 results
8-K
VIR
Vir Biotechnology Inc
29 May 24
Submission of Matters to a Vote of Security Holders
4:06pm
of Appointment of Independent Registered Public Accounting Firm
The Company’s stockholders ratified the appointment by the Audit Committee of the Company’s Board … of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
and strategy ESG initiatives These meetings were attended by the Independent Chair of our Compensation Committee and members of our management team
CONTINUING … since 2019 George Scangos, Ph.D. Former President & CEO, Vir Biotechnology Director since 2017 Vicki Sato, Ph.D. (Independent Chairman) Former
8-K
VIR
Vir Biotechnology Inc
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. as independent director nominees to stand for election at its 2024 Annual Meeting of Stockholders
8-K
EX-99.1
969aaxp mkg
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
S-8
ob37z516try98hq 4z
26 Feb 24
Registration of securities for employees
4:27pm
S-8
EX-23.1
5r4fui6jduhks8c
26 Feb 24
Registration of securities for employees
4:27pm
S-3ASR
EX-1.2
4o2u8j9ufu5qq0xravf4
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-4.6
0i79edtbkqv1qria
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-23.1
c6ty013w
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-4.5
b2pw6
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
846u8
3 Nov 23
Automatic shelf registration
4:33pm
8-K
ek9vzs4y
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am